The Year in Obesity Approvals and Regulatory Updates

Mon, Nov 16, 2026 · 3:30–4:30 PM EST Woodrow Wilson, Ballroom Level, Gaylord National Resort & Convention Center

About this session

Annual review by FDA’s Division of Diabetes, Lipid Disorders, and Obesity of obesity-related approvals, label updates, safety communications and upcoming regulatory issues.